EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Assessing healthy vaccinee effect in COVID-19 vaccine effectiveness studies: a national cohort study in Qatar

Hiam Chemaitelly iD, Houssein H Ayoub, Peter Coyle, Patrick Tang, Mohammad R Hasan, Hadi M Yassine, Asmaa A Al Thani, Zaina Al-Kanaani, Einas Al-Kuwari, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif und 10 weitere

eLife · 09.06.2025 · 14

DOI: 10.7554/elife.103690 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift eLife, online erschienen am 09.06.2025. Verfasst von Hiam Chemaitelly und 21 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Vaccine Efficacy. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Weill Cornell Medicine-Qatar, L'Oréal, United Nations Educational, Scientific and Cultural Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study investigated the presence of the healthy vaccinee effect—the imbalance in health status between vaccinated and unvaccinated individuals—in two rigorously conducted COVID-19 vaccine effectiveness studies involving primary series and booster vaccinations. It also examined the temporal patterns and variability of this effect across different subpopulations by analyzing the association between COVID-19 vaccination and non-COVID-19 mortality in Qatar.

Methods

Two matched, retrospective cohort studies assessed the incidence of non-COVID-19 death in national cohorts of individuals with a primary series vaccination versus no vaccination (two-dose analysis), and individuals with three-dose (booster) vaccination versus primary series vaccination (three-dose analysis), from January 5, 2021, to April 9, 2024.

Results

The adjusted hazard ratio (aHR) for non-COVID-19 death was 0.76 (95% CI: 0.64–0.90) in the two-dose analysis and 0.85 (95% CI: 0.67–1.07) in the three-dose analysis. In the first 6 months of follow-up in the two-dose analysis, the aHR was 0.35 (95% CI: 0.27–0.46); however, the combined analysis of all subsequent periods showed an aHR of 1.52 (95% CI: 1.19–1.94). In the first 6 months of follow-up in the three-dose analysis, the aHR was 0.31 (95% CI: 0.20–0.50); however, the combined analysis of all subsequent periods showed an aHR of 1.37 (95% CI: 1.02–1.85). The overall effectiveness of the primary series and third-dose vaccinations against severe, critical, or fatal COVID-19 was 95.9% (95% CI: 94.0–97.1) and 34.1% (95% CI: –46.4–76.7), respectively. Subgroup analyses showed that the healthy vaccinee effect is pronounced among those aged 50 years and older and among those more clinically vulnerable to severe COVID-19.

Conclusions

A pronounced healthy vaccinee effect was observed during the first 6 months following vaccination, despite meticulous cohort matching. This effect may have stemmed from a lower likelihood of vaccination among seriously ill, end-of-life individuals, and less mobile elderly populations. Funding: Biomedical Research Program and the Biostatistics, Epidemiology, and Biomathematics Research Core, and Junior Faculty Transition to Independence Program, all at Weill Cornell Medicine-Qatar, Qatar University, Ministry of Public Health, Hamad Medical Corporation, Sidra Medicine, Qatar Genome Programme, Qatar University Biomedical Research Center, and L’Oréal-UNESCO For Women In Science Middle East Regional Young Talents Program.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19COVID-19 VaccinesVaccine EfficacyHumansQatarMaleMiddle AgedRetrospective StudiesAdultFemaleSARS-CoV-2AgedVaccinationAdolescentYoung AdultImmunization, SecondaryChild

Stichwörter der Autor:innen

COVID-19all-cause mortalitybiascohort studyepidemiologyglobal healthvaccineviruses

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
  • World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - E…
  • Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, United States.
  • Mathematics Program, Department of Mathematics and Statistics, College of Arts and Sciences, Qatar University, Doha, Qatar.
  • Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
  • Hamad Medical Corporation, Doha, Qatar.

ORCID-Profile: Hiam Chemaitelly, Gheyath K Nasrallah, Laith J Abu-Raddad

Förderung

  • Weill Cornell Medicine-Qatar
  • L'Oréal
  • United Nations Educational, Scientific and Cultural Organization
  • Ministry of Public Health
  • Sidra Medicine
  • Hamad Medical Corporation
  • Qatar Genome Programme
  • Qatar University Biomedical Research Center

Zitieren

APA

Chemaitelly, H., Ayoub, H. H., Coyle, P., Tang, P., Hasan, M. R., Yassine, H. M., Al Thani, A. A., Al-Kanaani, Z., Al-Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul-Rahim, H. F., Nasrallah, G. K., Al-Kuwari, M. G., Al-Romaihi, H. E., Al-Thani, M. H., Al-Khal, A., …, & Abu-Raddad, L. J. (2025). Assessing healthy vaccinee effect in COVID-19 vaccine effectiveness studies: a national cohort study in Qatar. eLife, 14. https://doi.org/10.7554/elife.103690

Vancouver

Chemaitelly H, Ayoub HH, Coyle P, Tang P, Hasan MR, Yassine HM, et al. Assessing healthy vaccinee effect in COVID-19 vaccine effectiveness studies: a national cohort study in Qatar. eLife. 2025;14. doi:10.7554/elife.103690

BibTeX
@article{Chemaitelly2025,
  author = {Chemaitelly, Hiam and Ayoub, Houssein H and Coyle, Peter and Tang, Patrick and Hasan, Mohammad R and Yassine, Hadi M and Al Thani, Asmaa A and Al-Kanaani, Zaina and Al-Kuwari, Einas and Jeremijenko, Andrew and Kaleeckal, Anvar Hassan and Latif, Ali Nizar and Shaik, Riyazuddin Mohammad and Abdul-Rahim, Hanan F and Nasrallah, Gheyath K and Al-Kuwari, Mohamed Ghaith and Al-Romaihi, Hamad Eid and Al-Thani, Mohamed H and Al-Khal, Abdullatif and Bertollini, Roberto and Butt, Adeel A and Abu-Raddad, Laith J},
  title = {Assessing healthy vaccinee effect in COVID-19 vaccine effectiveness studies: a national cohort study in Qatar},
  journal = {eLife},
  year = {2025},
  volume = {14},
  doi = {10.7554/elife.103690}
}
Kostenlos starten →